| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Profile: Skinmedica, Inc.
Posted on 06/25/2007 09:44:02 | Link | Post Comment
BioHealth Investor Company Directory Profile
SkinMedica, Inc.
5909 Sea Lion Place
Suite H
Carlsbad, CA 92010 USA
Toll-Free: (877) 944-1412
Within San Diego Area: (760) 448-3600
Fax: (760) 448-3601
SkinMedica is a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin. Through our own sales force, we market and sell primarily to dermatologists both prescription pharmaceutical products and physician-dispensed, non-prescription skin care products, which we refer to as cosmeceuticals.
We currently market four pharmaceutical products: Desonate™ for the treatment of mild to moderate atopic dermatitis, VANIQA® for the reduction in growth of unwanted facial hair in women, EpiQuin® Micro for the treatment of hyperpigmentation and NeoBenz® Micro for the treatment of acne. Our cosmeceutical products, including our lead product line Tissue Nutrient Solution, or TNS™, are designed to enhance skin appearance, reduce signs of aging and provide other skin care benefits.
This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
SkinMedica, Inc.5909 Sea Lion Place
Suite H
Carlsbad, CA 92010 USA
Toll-Free: (877) 944-1412
Within San Diego Area: (760) 448-3600
Fax: (760) 448-3601
SkinMedica is a specialty pharmaceutical company focused on developing, acquiring and commercializing products that treat dermatologic conditions and diseases and improve the appearance of skin. Through our own sales force, we market and sell primarily to dermatologists both prescription pharmaceutical products and physician-dispensed, non-prescription skin care products, which we refer to as cosmeceuticals.
We currently market four pharmaceutical products: Desonate™ for the treatment of mild to moderate atopic dermatitis, VANIQA® for the reduction in growth of unwanted facial hair in women, EpiQuin® Micro for the treatment of hyperpigmentation and NeoBenz® Micro for the treatment of acne. Our cosmeceutical products, including our lead product line Tissue Nutrient Solution, or TNS™, are designed to enhance skin appearance, reduce signs of aging and provide other skin care benefits.
This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Credit Bloggers
- The Average Joe Investor
- Wishing Wealth
- Financial Skeptic
- Edmonton Real Estate
- Don't Mess With Taxes
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Tue Jul 22, 2008 09:23AM
Hedge funds have made billions this year shorting the banks, [read more]
Hedge funds have made billions this year shorting the banks, [read more]
<< My Home | TheMoneyBlogs Home